These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33168019)

  • 1. Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies.
    Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
    AIDS Res Ther; 2020 Nov; 17(1):65. PubMed ID: 33168019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies.
    Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
    AIDS Res Hum Retroviruses; 2020 Apr; 36(4):260-267. PubMed ID: 31608648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral treatment interruption among people living with HIV during COVID-19 outbreak in China: a nationwide cross-sectional study.
    Sun Y; Li H; Luo G; Meng X; Guo W; Fitzpatrick T; Ao Y; Feng A; Liang B; Zhan Y; Sande A; Xie F; Wang Y; Qian HZ; Cai Y; Zou H
    J Int AIDS Soc; 2020 Nov; 23(11):e25637. PubMed ID: 33247541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption.
    Neergaard R; Jones NL; Roebuck C; Rendle KA; Barbati Z; Peterson B; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dube K; Barg FK
    AIDS Res Hum Retroviruses; 2023 Aug; 39(8):414-421. PubMed ID: 35979886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding participant perspectives around HIV-1 cure-related studies involving antiretroviral analytical treatment interruptions in the United Kingdom.
    Lee MJ; Godakandaarachchi P; Collins S; Racz M; Sharp A; Fidler S; Fox J
    J Virus Erad; 2023 Dec; 9(4):100360. PubMed ID: 38188642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure Research.
    Dubé K; Auerbach JD; Stirratt MJ; Gaist P
    J Int AIDS Soc; 2019 Oct; 22(10):e25404. PubMed ID: 31665568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC).
    Protière C; Spire B; Mora M; Poizot-Martin I; Préau M; Doumergue M; Morlat P; Zucman D; Goujard C; Raffi F; Lambotte O; Suzan-Monti M
    PLoS One; 2017; 12(11):e0187489. PubMed ID: 29095883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.
    Dubé K; Kanazawa J; Campbell C; Boone CA; Maragh-Bass AC; Campbell DM; Agosto-Rosario M; Stockman JK; Diallo DD; Poteat T; Johnson M; Saberi P; Sauceda JA
    AIDS Res Hum Retroviruses; 2022 Jan; 38(1):50-63. PubMed ID: 33947268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of HIV cure research among people living with HIV in Australia.
    Power J; Westle A; Dowsett GW; Lucke J; Tucker JD; Sugarman J; Lewin SR; Hill S; Brown G; Wallace J; Richmond J
    PLoS One; 2018; 13(8):e0202647. PubMed ID: 30142171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States.
    Bilger A; Plenn E; Barg FK; Rendle KA; Carter WB; Lamour-Harrington A; Jones N; Peterson B; Sauceda JA; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dubé K
    HIV Res Clin Pract; 2023 Oct; 24(1):2267825. PubMed ID: 37837376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States.
    Dubé K; Ndukwe SO; Korolkova A; Dee L; Sugarman J; Sauceda JA
    HIV Res Clin Pract; 2024 Jan; 25(1):2312318. PubMed ID: 38348830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID-19 pandemic in China: a qualitative study.
    Sun Y; Zhan Y; Li H; Yuan T; Gao Y; Liang B; Feng A; Li P; Zheng W; Fitzpatrick T; Wu D; Zhai X; Zou H
    J Int AIDS Soc; 2021 Sep; 24(9):e25781. PubMed ID: 34473409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption.
    Okumu EA; Henderson GE; Golin C; Kuczynski K; Ormsby NQ; Peay HL
    J Virus Erad; 2023 Jun; 9(2):100331. PubMed ID: 37416088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual behaviour of people living with HIV attending a tertiary care government hospital in Kathmandu, Nepal: a cross sectional study.
    Angdembe MR; Lohani SP; Karki DK; Bhattarai K; Shrestha N
    BMC Res Notes; 2015 Nov; 8():629. PubMed ID: 26525742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions of HIV Virologic Control Strategies Among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey.
    Saberi P; Eskaf S; Sauceda J; Evans D; Dubé K
    AIDS Res Hum Retroviruses; 2020 Jul; 36(7):606-615. PubMed ID: 32368934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global survey of HIV-positive people's attitudes towards cure research.
    Simmons R; Kall M; Collins S; Cairns G; Taylor S; Nelson M; Fidler S; Porter K; Fox J;
    HIV Med; 2017 Feb; 18(2):73-79. PubMed ID: 27167600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I don't want them to know": how stigma creates dilemmas for engagement with Treat-all HIV care for people living with HIV in Eswatini.
    Horter S; Bernays S; Thabede Z; Dlamini V; Kerschberger B; Pasipamire M; Rusch B; Wringe A
    Afr J AIDS Res; 2019 Mar; 18(1):27-37. PubMed ID: 30782082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research.
    Dubé K; Kanazawa J; Dee L; Taylor J; Campbell DM; Brown B; Johnson MO; Saberi P; Sauceda JA; Sugarman J; Peluso MJ
    HIV Res Clin Pract; 2021 Feb; 22(1):14-30. PubMed ID: 33757411
    [No Abstract]   [Full Text] [Related]  

  • 19. Reaching the 'first 90': Gaps in coverage of HIV testing among people living with HIV in 16 African countries.
    Staveteig S; Croft TN; Kampa KT; Head SK
    PLoS One; 2017; 12(10):e0186316. PubMed ID: 29023510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions.
    Dubé K; Agarwal H; Carter WB; Dee L; Taylor J; Roebuck C; Peterson B; Patel H; Ndukwe S; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Bateman K; Howell BJ; Azzoni L; Mounzer K; Tebas P; Montaner LJ
    HIV Res Clin Pract; 2022 Aug; 23(1):76-90. PubMed ID: 35968737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.